138 related articles for article (PubMed ID: 3449081)
1. Synthesis and structure-activity relationships among glycosidic derivatives of 4'-demethylepipodophyllotoxin and epipodophyllotoxin, showing VM26- and VP16-213-like activities.
Gupta RS; Chenchaiah PC; Gupta R
Anticancer Drug Des; 1987 Aug; 2(1):1-12. PubMed ID: 3449081
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological activities of the C-4 esters of 4'-demethylepipodophyllotoxin.
Gupta RS; Chenchaiah PC
Anticancer Drug Des; 1987 Aug; 2(1):13-23. PubMed ID: 3449082
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of galactopyranoside derivatives of 4'-demethylepipodophyllotoxin showing VP-16 (etoposide)-like activity.
Pamidi CC; Derry WB; Gupta RS
Anticancer Drug Des; 1991 Nov; 6(5):481-93. PubMed ID: 1764166
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological activity of novel thymidine derivatives of podophyllotoxin and 4'-demethylepipodophyllotoxin.
Derry WB; Pamidi CC; Gupta RS
Anticancer Drug Des; 1993 Jun; 8(3):203-21. PubMed ID: 8517914
[TBL] [Abstract][Full Text] [Related]
5. 4'-Demethylepipodophyllotoxin-beta-D-glucoside: a new podophyllotoxin derivative with VM-26-like and VP-16-213-like activities.
Gupta RS; Singh B
J Natl Cancer Inst; 1984 Jul; 73(1):241-8. PubMed ID: 6588229
[TBL] [Abstract][Full Text] [Related]
6. Podophyllotoxin-resistant mutants of Chinese hamster ovary cells: cross-resistance studies with various microtubule inhibitors and podophyllotoxin analogues.
Gupta RS
Cancer Res; 1983 Feb; 43(2):505-12. PubMed ID: 6848174
[TBL] [Abstract][Full Text] [Related]
7. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1986 Aug; 46(8):3809-16. PubMed ID: 3015377
[TBL] [Abstract][Full Text] [Related]
8. Etoposide (VP16) and teniposide (VM26): novel anticancer drugs, strongly mutagenic in mammalian but not prokaryotic test systems.
Gupta RS; Bromke A; Bryant DW; Gupta R; Singh B; McCalla DR
Mutagenesis; 1987 May; 2(3):179-86. PubMed ID: 3325741
[TBL] [Abstract][Full Text] [Related]
9. Single- and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide.
Long BH; Musial ST; Brattain MG
Cancer Res; 1985 Jul; 45(7):3106-12. PubMed ID: 3839166
[TBL] [Abstract][Full Text] [Related]
10. Reduction of drug accumulation and DNA topoisomerase II activity in acquired teniposide-resistant human cancer KB cell lines.
Matsuo K; Kohno K; Takano H; Sato S; Kiue A; Kuwano M
Cancer Res; 1990 Sep; 50(18):5819-24. PubMed ID: 2168282
[TBL] [Abstract][Full Text] [Related]
11. Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP16-213.
Gupta RS
Cancer Res; 1983 Apr; 43(4):1568-74. PubMed ID: 6831403
[No Abstract] [Full Text] [Related]
12. Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-beta-D-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) and their metabolites on human leukemic lymphoblasts.
Dow LW; Sinkule JA; Look AT; Horvath A; Evans WE
Cancer Res; 1983 Dec; 43(12 Pt 1):5699-706. PubMed ID: 6580063
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congeners.
Loike JD; Brewer CF; Sternlicht H; Gensler WJ; Horwitz SB
Cancer Res; 1978 Sep; 38(9):2688-93. PubMed ID: 679171
[TBL] [Abstract][Full Text] [Related]
14. Etoposide (VP16-213) and teniposide (VM26) comparative in vitro activities in human tumors.
Issell BF; Tihon C; Curry ME
Cancer Chemother Pharmacol; 1982; 7(2-3):113-5. PubMed ID: 7083450
[TBL] [Abstract][Full Text] [Related]
15. Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
Gupta RS
Mol Pharmacol; 1986 Aug; 30(2):142-8. PubMed ID: 3736539
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
Chen SW; Tian X; Tu YQ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
Allen LM; Tejada F; Okonmah AD; Nordqvist S
Cancer Chemother Pharmacol; 1982; 7(2-3):151-6. PubMed ID: 7083456
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationship.
Long BH; Musial ST; Brattain MG
Biochemistry; 1984 Mar; 23(6):1183-8. PubMed ID: 6712942
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
[TBL] [Abstract][Full Text] [Related]
20. Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives.
Xiao Z; Bastow KF; Vance JR; Sidwell RS; Wang HK; Chen MS; Shi Q; Lee KH
J Med Chem; 2004 Oct; 47(21):5140-8. PubMed ID: 15456257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
